We came across a bullish thesis on Photronics, Inc. on Beeli Capital’s Substack by Andrew Beeli. In this article, we will summarize the bulls’ thesis on PLAB. Photronics, Inc.'s share was trading at $22.01 as of September 10th. PLAB’s trailing P/E was 12.44 according to Yahoo Finance. Taiwan Semiconductor Manufacturing Company Limited (TSM) Is Worried About High Construction Costs Of US Plants, Says Jim Cramer the-main-processor-3334336_1280 Photronics, Inc. (PLAB) is a leading manufacturer of photomask ...

I am rating Aeluma, Inc. (NASDAQ: NASDAQ: ALMU ) as a buy driven by contracts with NASA, the Department of Energy (DOE), and the US Navy. These contracts are a major driver of the FY2026 revenueFirst Principles Partners is an equity research analyst specializing in technology, innovation, and sustainability investment. My unique approach, "First Principles," involves breaking down complex problems to their most basic elements in terms of financial and technology, enabling me to uncover overlooked investment ...

We came across a bullish thesis on Natural Resource Partners L.P. on Scalper's Lounge’s Substack by scalpavelli. In this article, we will summarize the bulls’ thesis on NRP. Natural Resource Partners L.P. 's share was trading at $102.73 as of September 11th. NRP’s trailing P/E was 9.63 according to Yahoo Finance. Why Tamboran Resources Corporation (TBN) Is Gaining This Week? Copyright: vyacheslavsvetlichnyy / 123RF Stock Photo Natural Resources Partners LP (NRP) is a master limited partnership structure ...

Key Takeaways BWAY gained FDA clearance for an accelerated Deep TMS protocol for major depressive disorder.BWAY's new method shortens treatment to six days with results comparable to the standard approach.BWAY is preparing provider training and reimbursement updates to support wider adoption.BrainsWay Ltd. (BWAY) recently secured FDA clearance for an accelerated treatment protocol using its Deep Transcranial Magnetic Stimulation (TMS) system. The approval allows providers to treat patients with major depres ...

Key Takeaways Ulta Beauty's fragrance category rose double digits in Q2, reaching 12% of net sales.Growth came from gifting, exclusives, new launches, and expanded men's assortments.In-store conversion and brand events boosted premium and gift fragrance sell-through.Ulta Beauty, Inc.’s (ULTA) fragrance category delivered robust double-digit growth in the second quarter of fiscal 2025, emerging as the strongest-performing category for the period. Per the fiscal second-quarter earnings release, fragrance acco ...

We came across a bullish thesis on Protagonist Therapeutics, Inc. on BiotechBonanza’s Substack by AnotherBio. In this article, we will summarize the bulls’ thesis on PTGX. Protagonist Therapeutics, Inc.'s share was trading at $59.68 as of September 11th. PTGX’s trailing and forward P/E were 81.75 and 26.39 respectively according to Yahoo Finance. 10 Best Healthcare Dividend Stocks To Buy Protagonist Therapeutics (PTGX) presents a compelling investment case following strong clinical progress and underappr ...

Focus of Article: The focus of this two-part article is a very detailed analysis comparing Blackstone Secured Lending (NYSE:BXSL) to some of the company’s business development company (“BDC”) peers (all sector peers I currently fully cover). I am writing this two-part article due to the continued requests that such an analysis be specifically performed on BXSL and some of the company’s BDC peers at periodic intervals. For readers who just want the summarized conclusions/results, I would suggest to scroll do ...

Focus of Article: The focus of this two-part article is a very detailed analysis comparing Blackstone Secured Lending (NYSE:BXSL) to some of the company’s business development company (“BDC”) peers (all sector peers I currently fully cover). I am writing this two-part article due to the continued requests that such an analysis be specifically performed on BXSL and some of the company’s BDC peers at periodic intervals. For readers who just want the summarized conclusions/results, I would suggest to scroll do ...

The Ramsey Show/YouTube Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. Tom called into The Ramsey Show in early August, sharing what he called “quite the financial mess.” The 30-year-old former commercial real estate analyst from New Jersey is swimming in debt with four mortgages, a car loan, and a credit card — all to the tune of more than $1.8 million in debt. Must Read Before being laid off seven months ago, Tom earned $130,000 annually in commerc ...

We came across a bullish thesis on ARS Pharmaceuticals, Inc. on Value Degen’s Substack’s Substack by Unemployed Value Degen. In this article, we will summarize the bulls’ thesis on SPRY. ARS Pharmaceuticals, Inc.'s share was trading at $10.15 as of September 11th. ARS Pharmaceuticals (ARS) is positioned in the epinephrine delivery market with its nasal spray, Neffy, supported by a portfolio of patents covering composition, formulation, dosage, delivery devices, and absorption-enhancing companion drugs, w ...